Hospice Agencies Available for Sale Nationwide
A 2026 analysis of hospice and home health valuation multiples across the U.S. market. This report breaks down EBITDA multiples, explains how revenue ties into valuation, compares hospice vs home health trends, and outlines what buyers and sellers need to know in 2026.
Getting a hospice valuation is more than a number — it shapes your exit timing, buyer confidence, and deal terms. Here are 10 questions every hospice owner should ask an advisor before starting the valuation process.
The 2026 Final Rule and HOPE Tool are reshaping how hospice valuations are calculated. Learn how quality metrics, compliance, and data transparency affect your agency’s value — and how Vallexa Advisors helps owners navigate the changing market.
Discover how hospice valuations are determined and what truly drives your agency’s worth. Learn the factors buyers consider — from EBITDA to compliance — and how Vallexa Advisors helps hospice owners secure premium valuations through expert guidance, national reach, and success-only fees.
Looking to sell my healthcare business? Discover why Vallexa Advisors is the trusted M&A partner for healthcare owners, offering expert guidance, valuations, and buyer connections.